4-Isopropylamino-pyridine-2-carbonitrile | 127680-77-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-Isopropylamino-pyridine-2-carbonitrile
• 英文别名: 4-[(1-Methylethyl)amino]-2-pyridinecarbonitrile；4-(propan-2-ylamino)pyridine-2-carbonitrile
• CAS: 127680-77-7
• 化学式: C₉H₁₁N₃
• 分子量: 161.206
• InChiKey: GGWFZRWEMCINKS-UHFFFAOYSA-N

物化性质

• 沸点：
  312.9±27.0 °C(Predicted)
• 密度：
  1.07±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  48.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  异丙胺 、 吡啶-2,4-二腈 、 乙腈 生成 4-Isopropylamino-pyridine-2-carbonitrile
  参考文献：
  名称：

  BERNARDI, ROSANNA;CARONNA, TULLIO;MORROCCHI, SERGIO;URSINI, MAURIZIO;VITT+, J. CHEM. SOC. PERKIN TRANS. PT 1,(1990) N, C. 97-100

  摘要：

  DOI：

文献信息

• HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS
  申请人：Incyte Corporation

  公开号：US20180009816A1

  公开（公告）日：2018-01-11

  This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  这种应用涉及到式（I）的化合物： 或其药用可接受的盐或立体异构体，这些化合物是PI3K-γ的抑制剂，对于治疗自身免疫疾病、癌症、心血管疾病和神经退行性疾病等疾病是有用的。
• A study of the photochemically induced reaction of pyridine-2,4-dicarbonitrile with primary and secondary amines. A direct synthesis of aminocyano-pyridines
  作者：Rosanna Bernardi、Tullio Caronna、Sergio Morrocchi、Maurizio Ursini、Bruno M. Vittimberga

  DOI：10.1039/p19900000097

  日期：——

  A novel synthesis of alkylaminopyridinecarbonitriles by a photoinitiated substitution reaction between pyridine-2,4-dicarbonitrile and certain amines is described. The mechanism is discussed.

  描述了通过吡啶-2，4-二甲腈和某些胺之间的光引发的取代反应的烷基氨基吡啶甲腈的新颖合成。讨论了该机制。
• Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
  申请人：Incyte Corporation

  公开号：US10479795B2

  公开（公告）日：2019-11-19

  This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  本申请涉及式 (I) 化合物： 或其药学上可接受的盐或立体异构体，它们是 PI3K-γ 的抑制剂，可用于治疗自身免疫性疾病、癌症、心血管疾病和神经退行性疾病等疾病。
• Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
  申请人：Incyte Corporation

  公开号：US10975088B2

  公开（公告）日：2021-04-13

  This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  本申请涉及式 (I) 化合物： 或其药学上可接受的盐或立体异构体，它们是 PI3K-γ 的抑制剂，可用于治疗自身免疫性疾病、癌症、心血管疾病和神经退行性疾病等疾病。
• Bernardi, Rosanna; Caronna, Tullio; Poggi, Gabriella, Journal of Heterocyclic Chemistry, 1994, vol. 31, # 4, p. 903 - 908
  作者：Bernardi, Rosanna、Caronna, Tullio、Poggi, Gabriella、Vittimberga, Bruno M.

  DOI：——

  日期：——